Figure S25 from Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody–Drug Conjugates
Year: 2026
Type: other
Abstract: Figure S25. PET/CT imaging and biodistribution with [89Zr]DFO-YS5-MMAE in DU145 tumor-bearing mice. (A) Axial, coronal, and MIP PET/CT images of mice (M1–M3) at 24, 48, 96, and 168 hours post-injection show sustained tumor uptake of [89Zr]DFO*-YS5-MMAE. Color scale indicates %ID/g. (B) Organ distribution of [89Zr]DFO*-YS5-MMAE in DU145 bearing mice, at 168 h post-injections.
Authors: Anil P. Bidkar, Scott Bidlingmaier, Anju Wadhwa, Ellis Mayne, Athira Raveendran, Shubhankar Naik, Cheng Xue, Megha Basak, Kondapa Naidu Bobba, Bonell Patiño-Escobar, Nancy Greenland, Juan Antonio Camara Serrano, Veronica Steri, Jonathan Chou, Arun Wiita, Jiang He, David M. Wilson, Rahul Aggarwal, Henry F. VanBrocklin, Youngho Seo, Bin Liu, Robert R. Flavell
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165025860